We are here to help you protect your legal rights! Call Us at (800) 672-4916

Wall Street Journal: Health

Syndicate content WSJ.com: Health
Health
Updated: 1 hour 37 min ago

Merck's Profit Falls 52%

2 hours 16 min ago
Merck reported a 52% drop in profit, as the drug maker booked merger and restructuring costs.

Geron to Resume Stem-Cell Study

2 hours 56 min ago
Geron can proceed with early testing of an embryonic-stem-cell treatment for spinal-cord injuries after the FDA lifted a nearly yearlong hold on the trial.

Sanofi Net Jumps 61%

Thu, 07/29/2010 - 21:20
Sanofi-Aventis reported a 61% rise in net profit and will conduct "another re-evaluation" of the structure of its U.S. sales force in light of looming generic competition to the company's blockbuster drug Lovenox.

Health Bill's New Tax Rules Under Fire

Thu, 07/29/2010 - 20:33
Democrats may water down or repeal new tax-reporting rules that are supposed to raise $16 billion for health-care legislation, facing a chorus of criticism about the rules.

Americans Cut Back on Doctor Visits

Thu, 07/29/2010 - 11:34
Insured Americans are using fewer medical services, raising questions about whether patients are consuming less care as they pick up more of the cost.

Sanofi Nearer to Genzyme Bid

Thu, 07/29/2010 - 07:20
Sanofi is likely to make a formal bid to Genzyme's board in an effort to win enough support for a deal that could eventually be valued at about $20 billion.

Key Drugs Boost AstraZeneca

Thu, 07/29/2010 - 04:16
AstraZeneca posted a 23% rise in profit, helped by a strong performance in emerging markets and sales of key drugs like cholesterol product Crestor.

In Many CPRs, Skip Mouth-to-Mouth

Wed, 07/28/2010 - 20:33
Two new studies bolster a shift in thinking about how to revive many cardiac-arrest patients: Don't do mouth-to-mouth resuscitation.

Nvidia Warns of Sales Shortfall

Wed, 07/28/2010 - 18:12
Nvidia lowered its second-quarter revenue estimates, amid weak consumer spending that weighed on sales of its flagship graphics processing chips.

Eli Lilly Loses Appeal in Gemzar Patent Case

Wed, 07/28/2010 - 17:05
A federal appeals court ruled Wednesday that an Eli Lilly Co. patent for anti-cancer drug Gemzar is invalid, a decision that may clear the way for generic competition to the drug late this year.

AstraZeneca Anticlotting Drug Wins Support

Wed, 07/28/2010 - 16:31
An FDA panel backed an anticlotting drug being developed by AstraZeneca despite concerns about its effectiveness.

Aetna Contracts CVS to Run PBM

Tue, 07/27/2010 - 22:31
Aetna is contracting out its pharmacy-benefit business to CVS Caremark in a 12-year deal, and the health insurer posted a 42% increase in profit.

UnitedHealth in Talks on Purchase

Tue, 07/27/2010 - 22:20
UnitedHealth Group is in advanced talks to buy closely held Executive Health Resources Inc., a provider of medical management services to physicians, for about $1.5 billion.

New Nutritionist: Your Grocer

Tue, 07/27/2010 - 21:47
A number of grocery retailers are now pushing nutritional advice. Efforts include posting nutritional ratings on bin labels and hiring dietitians to advise shoppers on how to select healthier food.

Happy Couples, Go Ahead and Fight

Tue, 07/27/2010 - 16:59
Couples fight. The good news: If you fight the right way it can actually make your relationship happier and healthier.

St. Jude Says Ex-Executive Violated Pact by Joining Medtronic

Tue, 07/27/2010 - 13:59
St. Jude Medical believes a former top executive with access to "copious amounts" of confidential information violated an employment agreement by leaving and quickly joining heart-device rival Medtronic.

The Do-It-Yourself House Call

Tue, 07/27/2010 - 12:01
Insurer-endorsed remote-monitoring technology leads heart patients to take their own readings at home.

Doctors Fight Cosmetic Foot Surgery

Tue, 07/27/2010 - 11:21
Toe shortening, toe lengthening and injections into the pads of the feet are among cosmetic foot procedures blasted by the American Orthopaedic Foot and Ankle Society.

Merck in Talks for China Partnership

Tue, 07/27/2010 - 10:34
Merck is in talks with China's Sinopharm for a venture to market vaccines and, potentially, Merck drugs.

A Long Legacy of Affection

Tue, 07/27/2010 - 07:19
The stress-reducing effects of affectionate mothering might last into children's mid-30s, according to a study in the Journal of Epidemiology and Community Health.